Skip to content
2000
Volume 21, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Introduction

This study aims to evaluate the diagnostic value of extracellular volume fraction (ECV) and spectral CT parameters in assessing the pathological grading of lung invasive adenocarcinoma (IAC) presenting as solid or subsolid nodules.

Methods

A retrospective collection of patients who were pathologically confirmed as IAC with solid or subsolid pulmonary nodules at our hospital from March 2023 to November 2024 was conducted. Relevant data were recorded, and the patients were divided into two groups: intermediate/high differentiation and low differentiation. The parameters including arterial phase iodine concentration (IC), arterial phase normalized iodine concentration (NIC), arterial phase normalized effective atomic number (nZeff), arterial phase extracellular volume fraction (ECV), venous phase iodine concentration (IC), venous phase Normalized Iodine Concentration (NIC), venous phase normalized effective atomic number (nZeff), and venous phase extracellular volume fraction (ECV) were compared between the two groups. Parameters with statistical significance were evaluated for their diagnostic performance using Receiver Operating Characteristic (ROC) curves.

Results

A total of 61 patients were included, comprising 40 in the intermediate to high differentiation group and 21 in the low differentiation group. The intermediate/high differentiation group had higher values of ECV, NIC, ECV, IC, NIC, and nZeff than the low differentiation group ( < 0.05). The AUC values for these parameters were 0.679, 0.620, 0.757, 0.688, 0.724 and 0.693 respectively. Among these, ECV had the largest AUC, with a sensitivity and specificity of 72.5% and 71.4%, respectively. Through binary logistic regression analysis, five features were identified: the maximum diameter of the lesion, bronchus encapsulated air sign, lobulation sign, spiculation sign, and pleural traction sign. The integration of these imaging features with ECV resulted in a model with enhanced diagnostic performance, characterized by an AUC of 0.886, a sensitivity of 85.7%, and a specificity of 80.0%.

Discussion

ECV outperforms other spectral parameters in differentiating IAC grades, reflecting changes in the tumor microenvironment. Combining ECV with imaging features enhances diagnostic accuracy, though the study’s single-center design and small sample size limit generalizability.

Conclusion

Extracellular volume fraction can provide more information for the pathological grading assessment of invasive adenocarcinoma of the lung. Compared to other spectral parameters, ECV exhibits the highest diagnostic performance, and its combination with conventional imaging features can further enhance diagnostic accuracy.

© 2025 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cmir/10.2174/0115734056392707250818063540
2025-08-26
2025-10-29

  • From This Site

    /content/journals/cmir/10.2174/0115734056392707250818063540
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cmir/21/1/CMIR-21-E15734056392707.html?itemId=/content/journals/cmir/10.2174/0115734056392707250818063540&mimeType=html&fmt=ahah

References

  1. BrayF. LaversanneM. SungH. FerlayJ. SiegelR.L. SoerjomataramI. JemalA. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202474322926310.3322/caac.2183438572751
     [Google Scholar]
  2. LeiterA. VeluswamyR.R. WisniveskyJ.P. The global burden of lung cancer: Current status and future trends.Nat. Rev. Clin. Oncol.202320962463910.1038/s41571‑023‑00798‑337479810
     [Google Scholar]
  3. ButnorK.J. Controversies and challenges in the histologic subtyping of lung adenocarcinoma.Transl. Lung Cancer Res.20209383984610.21037/tlcr.2019.12.3032676350
     [Google Scholar]
  4. LiX. GaoZ. DiaoH. GuoC. YuY. LiuS. FengZ. PengZ. Lung adenocarcinoma: Selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity.Front. Oncol.202414132662610.3389/fonc.2024.132662638505588
     [Google Scholar]
  5. HuoJ. MinX. LuoT. LvF. FengY. FanQ. WangD. MaD. LiQ. Computed tomography-based 3D convolutional neural network deep learning model for predicting micropapillary or solid growth pattern of invasive lung adenocarcinoma.Radiol. Med. 2024129577678410.1007/s11547‑024‑01800‑338512613
     [Google Scholar]
  6. FotiG AscentiG AgostiniA LongoC LombardoF InnoA Dual-energy CT in oncologic imaging.Tomography202410329931910.3390/tomography10030024
     [Google Scholar]
  7. AndersenM.B. EbbesenD. ThygesenJ. KruisM. RasmussenF. Impact of spectral body imaging in patients suspected for occult cancer: A prospective study of 503 patients.Eur. Radiol.202030105539555010.1007/s00330‑020‑06878‑732367416
     [Google Scholar]
  8. WenQ. YueY. ShangJ. LuX. GaoL. HouY. The application of dual-layer spectral detector computed tomography in solitary pulmonary nodule identification.Quant. Imaging Med. Surg.202111252153210.21037/qims‑20‑233532253
     [Google Scholar]
  9. ZhangG. LiS. YangK. ShangL. ZhangF. HuangZ. RenJ. ZhangZ. ZhouJ. PuH. ManQ. KongW. The value of dual-energy spectral CT in differentiating solitary pulmonary tuberculosis and solitary lung adenocarcinoma.Front. Oncol.202212100002810.3389/fonc.2022.100002836531032
     [Google Scholar]
  10. OdaS. EmotoT. NakauraT. KidohM. UtsunomiyaD. FunamaY. NagayamaY. TakashioS. UedaM. YamashitaT. TsujitaK. AndoY. YamashitaY. Myocardial late iodine enhancement and extracellular volume quantification with dual-layer spectral detector dual-energy cardiac CT.Radiol. Cardiothorac. Imaging201911e18000310.1148/ryct.201918000333778497
     [Google Scholar]
  11. BaiX.H. YinJ. YuS.Y. ShuY.P. LuZ.P. JiangK.R. XuQ. Extracellular volume fraction derived from dual-energy CT: A potential predictor for acute pancreatitis after pancreatoduodenectomy.Eur. Radiol.202434116957696610.1007/s00330‑024‑10750‑338760508
     [Google Scholar]
  12. SofueK. UeshimaE. MasudaA. ShirakawaS. ZenY. UenoY. TsujitaY. YamaguchiT. YabeS. TanakaT. InomataN. ToyamaH. FukumotoT. KodamaY. MurakamiT. Estimation of pancreatic fibrosis and prediction of postoperative pancreatic fistula using extracellular volume fraction in multiphasic contrast-enhanced CT.Eur. Radiol.20223231770178010.1007/s00330‑021‑08255‑434636963
     [Google Scholar]
  13. JiangX. MaQ. ZhouT. FengQ. YangW. ZhouX. HuangW. LinX. LiJ. ZhangX. LiuS. XinX. FanL. Extracellular volume fraction as a potential predictor to differentiate lung cancer from benign lung lesions with dual-layer detector spectral CT.Quant. Imaging Med. Surg.202313128121813110.21037/qims‑23‑73638106275
     [Google Scholar]
  14. GuoW. LvB. YangT. TianM. LiuM. LinX. ZhaoP. Role of dynamic contrast-enhanced magnetic resonance imaging parameters and extracellular volume fraction as predictors of lung cancer subtypes and lymph node status in non-small-cell lung cancer patients.J. Cancer202314163108311610.7150/jca.8836737859821
     [Google Scholar]
  15. WangX. DuL. CaoY. ChenH. ShiJ. ZengX. LanX. HuangH. JiangS. LinM. ZhangJ. Comparing extracellular volume fraction with apparent diffusion coefficient for the characterization of breast tumors.Eur. J. Radiol.202417111126810.1016/j.ejrad.2023.11126838159522
     [Google Scholar]
  16. OxburghL. The extracellular matrix environment of clear cell renal cell carcinoma.Cancers20221417407210.3390/cancers1417407236077607
     [Google Scholar]
  17. FukukuraY. KumagaeY. HigashiR. HakamadaH. NakajoM. MaemuraK. ArimaS. YoshiuraT. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.Eur. Radiol.20203031679168910.1007/s00330‑019‑06517‑w31728691
     [Google Scholar]
  18. SolisL.M. BehrensC. RasoM.G. LinH.Y. KadaraH. YuanP. GalindoH. TangX. LeeJ.J. KalhorN. WistubaI.I. MoranC.A. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome.Cancer2012118112889289910.1002/cncr.2658422020674
     [Google Scholar]
  19. AkhaveN. ZhangJ. BayleyE. FrankM. ChiouS.H. BehrensC. ChenR. HuX. ParraE.R. LeeW.C. SwisherS. SolisL. WeissferdtA. MoranC. KalhorN. ZhangJ. ScheetP. VaporciyanA.A. SepesiB. GibbonsD.L. HeymachJ.V. LeeJ.J. WistubaI.I. Andrew FutrealP. ZhangJ. FujimotoJ. ReubenA. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment.Lung Cancer2022172192810.1016/j.lungcan.2022.08.00735973335
     [Google Scholar]
  20. IwanoS. ItoR. UmakoshiH. ItoS. NaganawaS. Evaluation of lung cancer by enhanced dual-energy CT: Association between three-dimensional iodine concentration and tumour differentiation.Br. J. Radiol.20158810552015022410.1259/bjr.2015022426329466
     [Google Scholar]
  21. KaramanosN.K. TheocharisA.D. PiperigkouZ. ManouD. PassiA. SkandalisS.S. VyniosD.H. Orian-RousseauV. Ricard-BlumS. SchmelzerC.E.H. DucaL. DurbeejM. AfratisN.A. TroebergL. FranchiM. MasolaV. OnistoM. A guide to the composition and functions of the extracellular matrix.FEBS J.2021288246850691210.1111/febs.1577633605520
     [Google Scholar]
  22. CroftM. LimW. LavenderN. GormlyK. Optimising CT‐chest protocols and the added value of venous‐phase contrast timing; Observational case‐control.J. Med. Imaging Radiat. Oncol.202266676877510.1111/1754‑9485.1335034799981
     [Google Scholar]
  23. KawaharaD. OzawaS. YokomachiK. TanakaS. HigakiT. FujiokaC. SuzukiT. TsunedaM. NakashimaT. OhnoY. NagataY. Accuracy of the raw-data-based effective atomic numbers and monochromatic CT numbers for contrast medium with a dual-energy CT technique.Br. J. Radiol.20179110822017052410.1259/bjr.2017052429161881
     [Google Scholar]
  24. ShenH. HuangY. YuanX. LiuD. TuC. WangY. LiX. WangX. ChenQ. ZhangJ. Using quantitative parameters derived from pretreatment dual-energy computed tomography to predict histopathologic features in head and neck squamous cell carcinoma.Quant. Imaging Med. Surg.20221221243125610.21037/qims‑21‑65035111620
     [Google Scholar]
/content/journals/cmir/10.2174/0115734056392707250818063540
Loading
Preliminary Study on the Evaluation Value of Extracellular Volume Fraction in the Pathological Grading of Lung Invasive Adenocarcinoma
Curr. Med. Imaging 21, E15734056392707 (2025); https://doi.org/10.2174/0115734056392707250818063540
/content/journals/cmir/10.2174/0115734056392707250818063540
/content/journals/cmir/10.2174/0115734056392707250818063540
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Adenocarcinoma; Differential diagnosis; Dual-energy CT imaging; ECVA; Lung neoplasms; Tomography; X-ray computed

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test